Seelos Therapeutics, Inc. (SEEL) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts SEEL Hot Sheet
Join SI Premium – FREE
Seelos Therapeutics, Inc. (NASDAQ: SEEL) reported Q1 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Seelos Therapeutics, Inc. (SEEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Redburn starts Mettler-Toledo at Sell, sees valuation outpacing growth
- Ollie's Bargain Outlet (OLLI) Tops Q2 EPS by 28c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
